CAMP

Oversold Stocks in Health Care: The health care sector has several oversold stocks, including Edgewise Therapeutics, Genfit, and CAMP4 Therapeutics, which present potential buying opportunities due to their low RSI values indicating they may be undervalued.

Recent Stock Performance: Edgewise Therapeutics' stock recently gained 8.8% despite a significant drop over the past month, while Genfit and CAMP4 Therapeutics have also seen declines, highlighting volatility and potential for recovery in these companies.

CalAmp's Participation in STN East Conference: CalAmp will showcase its telematics and fleet intelligence solutions at the STN East Conference on March 24, 2025, aiming to connect with student transportation professionals and share industry insights.

Focus on Student Safety and Efficiency: The company emphasizes its commitment to enhancing student safety and operational efficiency for over 1,000 school districts in the US and Canada through real-time data and innovative technology.

Clinical Progress: CAMP4 Therapeutics reported favorable safety results from the Single Ascending Dose (SAD) portion of its Phase 1 study for CMP-CPS-001, a treatment for urea cycle disorders, and has completed dosing in the first two Multiple Ascending Dose (MAD) cohorts, with key data expected in the second half of 2025.

Corporate Developments: The company successfully completed its IPO, was added to the Russell 2000® Index, and initiated a new discovery program targeting Parkinson's disease, while also entering a strategic partnership with BioMarin Pharmaceutical Inc.

DocuSign Financial Results: DocuSign, Inc. shares surged 14.1% in pre-market trading after reporting third-quarter revenue of $754.8 million and adjusted earnings of 90 cents per share, both exceeding analyst expectations.

Pre-Market Stock Movements: Various stocks experienced significant fluctuations in pre-market trading, with Universe Pharmaceuticals gaining 196.2% and Oriental Rise Holdings dropping 81.2%, highlighting a volatile market environment.

CAMP4 Therapeutics Presentation: CAMP4 Therapeutics will present at the Piper Sandler 36th Annual Healthcare Conference in New York City from December 3rd to 5th, 2024, with a live webcast available on their investor relations website.

Company Overview and Goals: CAMP4 is focused on developing regRNA-targeting therapeutics aimed at restoring healthy protein levels for various genetic diseases, utilizing their proprietary RAP Platform™ to amplify mRNA and target specific gene expressions.

Kura Oncology Analyst Ratings: Analysts have a Strong Buy consensus for Kura Oncology, with price targets suggesting a potential upside of 175.9% from its current share price of $10.80.

Bruker and CAMP4 Therapeutics Outlook: Both Bruker and CAMP4 Therapeutics also received Buy ratings from analysts, indicating moderate to strong buy sentiments, with significant upside potential in their respective price targets.

CAMP4 Therapeutics IPO and Developments: CAMP4 Therapeutics Corporation priced its IPO at $11.00 per share, raising approximately $75 million, and has initiated a Phase 1 study for its therapy CMP-CPS-001 targeting urea cycle disorders, which has received FDA Orphan Drug and Rare Pediatric Disease Designations.

Market Analysis and Future Projections: Analysts from William Blair and Piper Sandler have initiated coverage on CAMP4, highlighting its innovative RAP platform and potential for significant revenue growth, with expectations of FDA approval for CMP-CPS-001 by 2029 and peak revenues reaching $1 billion by 2036.

Real-time Intelligence: Benzinga Pro offers traders the fastest and most accurate stock market intelligence, helping them make informed decisions daily.

Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and alerts generated by Benzinga reporters.

Real-time Intelligence: Benzinga Pro offers traders the fastest and most accurate stock market intelligence, helping them make informed decisions daily.

Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and alerts generated by Benzinga reporters.

Recent IPOs: Polyrizon and Gelteq debuted on October 29, with Polyrizon opening at $1.64 after pricing its units at $4.38, while Gelteq opened at $4.00 after pricing its shares at the same amount. Both companies focus on innovative biotech solutions, with Polyrizon developing nasal spray hydrogels and Gelteq specializing in ingestible gel technology.

Upcoming IPOs: Several companies, including Pony AI, Infinity Natural Resources, Basel Medical Group, ShipBob, and Rivus Pharmaceuticals, are preparing for initial public offerings, with some expected to list soon on major stock exchanges like Nasdaq and NYSE.

Core & Main Inc CNM:

• Reported mixed first-quarter financial results, with earnings below market expectations but sales slightly above estimates.
• Shares fell sharply by 11.4% to $49.77 following the announcement.

Other Stocks Moving:

• MicroAlgo Inc MLGO shares surged 284% after announcing a quantum research center partnership.
• Sobr Safe Inc SOBR rose 112% due to new device purchases.
• Annexon, Inc. ANNX climbed 40% following positive Phase 3 trial results.
• Several other companies saw stock price increases ranging from 5.6% to 40%.

Stocks Declining:

• Various companies experienced declines ranging from 5.5% to 66.4%.
• Reasons for drops included missed earnings, downbeat financial results, and general market movements.

Specific Companies Affected:

• Notable decliners include GameStop Corp GME, HDFC Bank Ltd HDB, and CalAmp Corp CAMP.
• Rising stocks included CareCloud Inc CCLD, SkyWest Inc SKYW, and others.

Market Trends:

• Indian stocks like ICICI Bank Ltd IBN and HDFC Bank Ltd HDB fell amid early election results.
• Some companies announced significant deals or partnerships leading to stock surges.

Biggest Pre-Market Stock Movers:

• MicroAlgo (NASDAQ:MLGO) stock surges over 205% due to a joint research center announcement with WIMI (NASDAQ:WIMI).
• Fresh2 Group (NASDAQ:FRES) shares rise by 74% with heavy pre-market trading.
• Core Scientific (NASDAQ:CORZ) stock jumps more than 48% on an AI infrastructure deal.
• Annexon (NASDAQ:ANNX) shares increase over 33% based on positive Phase 3 clinical trial results.
• Plutonian Acquisition (NASDAQ:PLTN) stock rises close to 30% without specific news.

10 Top Losers:

• Lufax (NYSE:LU) stock drops by more than 51% without apparent news.
• Hywin (NASDAQ:HYW) shares dive over 24% after a significant rally the previous day.
• Avalon Globocare (NASDAQ:ALBT) stock tumbles more than 20% following a major rally.
• Binah Capital (NASDAQ:BCG) shares fall over 17% without any reported news.
• CalAmp (NASDAQ:CAMP) stock slides more than 15% post a bankruptcy filing.

• Dow Jones fell over 300 points, while NASDAQ and S&P 500 also saw declines.
• Health care shares rose, but energy shares fell by 3.2%.

• Bio-Path Holdings and Microbot Medical shares surged after positive announcements.
• GameStop Corp. shares increased following a Reddit post.

• CalAmp Corp. shares dropped significantly due to restructuring.
• Lattice Semiconductor Corporation and CNS Pharmaceuticals saw declines.

• Oil prices decreased, while gold, silver, and copper prices rose.

• European shares were mostly higher, with improvements in manufacturing PMI.
• Asian markets closed mostly higher, with gains in Japan's Nikkei and India's S&P BSE Sensex.

Science Applications International Corporation (SAIC):

• Reported a 9% revenue decline in the fiscal first quarter of 2025, leading to an 11% drop in shares.
• Adjusted EPS was $1.92, in line with analyst estimates.

Stock Movements:

• Microbot Medical Inc. and Bio-Path Holdings saw significant stock jumps.
• GameStop Corp. shares climbed after Roaring Kitty shared his position on Reddit.
• Several other companies experienced notable gains, including Professional Diversity Network and MarineMax, among others.

Stock Declines:

• Various companies faced declines, such as CalAmp Corp., Ault Disruptive Technologies Corporation, CNS Pharmaceuticals, and more.
• The Boston Beer Company shares fell following sale speculation reports.

Other Market Updates:

• AMC Entertainment Holdings and Novavax saw gains.
• Dell Technologies reported a decline despite upbeat earnings and sales results.

Industry Developments:

• GSK plc plans to appeal a ruling regarding ranitidine litigation.
• Lattice Semiconductor announced an interim CEO following leadership changes.